These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24331823)

  • 41. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
    Kiellberg Larsen H; Kofoed K; Sand C
    Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HPV vaccine update: new indications and controversies.
    Mendoza N; Hernandez PO; Tyring SK
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
    Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
    Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
    Watson M; Saraiya M; Ahmed F; Cardinez CJ; Reichman ME; Weir HK; Richards TB
    Cancer; 2008 Nov; 113(10 Suppl):2841-54. PubMed ID: 18980203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human papillomavirus vaccines and prevention of cervical cancer.
    Jansen KU; Shaw AR
    Annu Rev Med; 2004; 55():319-31. PubMed ID: 14746524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
    Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
    Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HPV vaccines: state of the art.
    D'Andrilli G; Bovicelli A; Giordano A
    J Cell Physiol; 2010 Sep; 224(3):601-4. PubMed ID: 20432468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.
    Luciani S; Jauregui B; Kieny C; Andrus JK
    Immunotherapy; 2009 Sep; 1(5):795-807. PubMed ID: 20636024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
    Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
    Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lung Cancer in the Middle East and North Africa Region.
    Jazieh AR; Algwaiz G; Errihani H; Elghissassi I; Mula-Hussain L; Bawazir AA; Gaafar R
    J Thorac Oncol; 2019 Nov; 14(11):1884-1891. PubMed ID: 31668315
    [No Abstract]   [Full Text] [Related]  

  • 56. Coming soon: vaccines that beat cancer.
    Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):4-5. PubMed ID: 12712966
    [No Abstract]   [Full Text] [Related]  

  • 57. Has UNAIDS left the Middle East and north Africa behind?
    Rizk NA; El Helou R; AlMukdad S; Fahme S; Mumtaz GR; Chemaitelly H; Ayoub HH; Osman A; Himmich H; Karkouri M; Al Khal A; Hassany M; Abu-Raddad LJ
    Lancet HIV; 2023 Oct; 10(10):e630-e632. PubMed ID: 37678312
    [No Abstract]   [Full Text] [Related]  

  • 58. Simulating HIV dynamics in the Middle East and north Africa.
    Karamouzian M; Sharifi H
    Lancet HIV; 2022 Jul; 9(7):e454-e455. PubMed ID: 35777405
    [No Abstract]   [Full Text] [Related]  

  • 59. North Africa & Middle East.
    Glob Heart; 2018 Sep; 13(3):165-169. PubMed ID: 30360787
    [No Abstract]   [Full Text] [Related]  

  • 60. Gender and HIV in the Middle East and North Africa: lessons for low prevalence scenarios.
    Shawky S; Soliman C; Sawires S
    J Acquir Immune Defic Syndr; 2009 Jul; 51 Suppl 3():S73-4. PubMed ID: 19553781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.